Why it was recalled
CGMP deviations: tablets with black specks.
Product description
Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
Lot numbers, UPCs & expiration codes
Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
Where it was sold
USA Nationwide
What to do if you have this product
- Compare the lot number and expiration date on your package with the codes above.
- Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
- If you have symptoms you think are related, contact your doctor. In an emergency call 911.
- Report side effects to FDA MedWatch at 1-800-FDA-1088.
Recall details
- Recall number
- D-0771-2026
- Classification
- Class II
- Status
- Ongoing
- Recall initiated
- Aug 7, 2026
- FDA report date
- Aug 26, 2026
- Quantity
- 1200 bottles
- Recall type
- Voluntary: Firm initiated
- Recalling firm
- Golden State Medical Supply Inc.
Original FDA data
Every field from FDA enforcement report D-0771-2026, exactly as published.
Show all FDA fields
- City
- Camarillo
- State
- CA
- Status
- Ongoing
- Country
- United States
- Event ID
- 99614
- Address
- 5187 Camino Ruiz
- Code information
- Lot #: a) GS067429, GS068091, Exp 5/31/2028; b) GS067430, GS068090, Exp 5/31/2028
- Postal code
- 93012-8601
- Report date
- Aug 26, 2026
- Product type
- Drugs
- Recall number
- D-0771-2026
- Classification
- Class II
- Recalling firm
- Golden State Medical Supply Inc.
- Product quantity
- 1200 bottles
- Reason for recall
- CGMP deviations: tablets with black specks.
- Voluntary / mandated
- Voluntary: Firm initiated
- Product description
- Carbamazepine Tablets, USP, 200mg, packaged in a)1000-count bottles (NDC 51407-215-10), b) 100-count bottles (NDC 51407-215-01), Rx Only, Manufactured by: Taro Pharmaceutical Industries Ltd., Marketed by: GSMS, Incorporated, Camarillo, CA 93012 USA
- Distribution pattern
- USA Nationwide
- Recall initiation date
- Aug 7, 2026
- Initial firm notification
- Letter
- Center classification date
- Aug 19, 2026